Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,568.00
+15.90 (1.02%)
Dec 19, 2025, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 211.42 billion as of December 19, 2025. Its market cap has increased by 6.27% in one year.
Market Cap
211.42B
Enterprise Value
238.69B
Revenue
29.86B
Ranking
n/a
PE Ratio
50.96
Stock Price
1,568.00
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 211.42B, an increase of 155.63%. That is a compound annual growth rate of 11.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 211.42B | 13.06% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | 78.75B | 20.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 994.77B |
| Zydus Lifesciences | 919.35B |
| Mankind Pharma | 884.23B |
| Aurobindo Pharma | 702.36B |
| Alkem Laboratories | 660.12B |